Systemic lupus erythematosus (SLE) afflicts more than a million Americans, primarily women, and presents with symptoms resulting from the involvement of practically every organ. The origin of the disease involves diverse factors which probably contribute variably to the expression of the disease in each patient. Understanding of the molecular underpinnings that lead to an aberrant immune response through this line of research has helped us identify novel treatment targets and biomarkers. Engagement of the CD3/T cell receptor complex in SLE T cells results in early and enhanced signaling response which has been linked to decreased presence of the CD3?, aggregated lipid rafts and increased expression of the adhesion molecule CD44. Study of CD3? deficient mice revealed parallels to human SLE T cells and a noted infiltration of T cells in to various tissues including the kidney. The new information compelled the address the testable hypothesis that decreased expression of CD3? in T cells forces the formation of aggregated lipid rafts, the expression of CD44, the production of interferon-? and the ability to infiltrate target tissues. I two sets of experiments using novel engineered mice we will understand the mechanisms whereby decreased or absent expression of CD3? renders T cells able to infiltrate tissues and how manipulation of lipid rafts can mitigate organ damage resulting from T cell infiltration. In parallel, in a prospective study of SLE patients the expression of CD44 and the use of a homemade expression array of genes claimed important in the immunopathogenesis of SLE will be test their ability to serve as disease biomarkers. The significance of the proposed studies lies with the identification of novel targets and the development of biomarkers. The study of the contribution of T cells to tissue inflammation in SLE using novel engineered mice presents a unique opportunity. Furthermore, the use of our gene expression array opens the way to personalized approach to SLE.

Public Health Relevance

Systemic lupus erythematosus afflicts more than a million Americans, primarily women, and presents with symptoms resulting from the involvement of practically every organ. The origin of the disease involves diverse factors which probably contribute variably to the expression of the disease in each patient. Understanding of the molecular underpinnings that lead to an aberrant immune response through this line of research will help us identify novel treatment targets and biomarkers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI042269-17
Application #
8579573
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Johnson, David R
Project Start
1998-07-15
Project End
2018-05-31
Budget Start
2013-06-20
Budget End
2014-05-31
Support Year
17
Fiscal Year
2013
Total Cost
$408,900
Indirect Cost
$173,900
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Hedrich, Christian M; Crispin, Jose C; Rauen, Thomas et al. (2014) cAMP responsive element modulator (CREM) * mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells. J Biol Chem 289:2361-70
Hedrich, Christian M; Rauen, Thomas; Apostolidis, Sokratis A et al. (2014) Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling. Proc Natl Acad Sci U S A 111:13457-62
Moulton, Vaishali R; Gillooly, Andrew R; Tsokos, George C (2014) Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells. J Biol Chem 289:4126-34
Grammatikos, Alexandros P; Kyttaris, Vasileios C; Kis-Toth, Katalin et al. (2014) A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus. Clin Immunol 150:192-200
Muroya, Takashi; Kannan, Lakshmi; Ghiran, Ionita C et al. (2014) C4d deposits on the surface of RBCs in trauma patients and interferes with their function. Crit Care Med 42:e364-72
Hedrich, Christian M; Rauen, Thomas; Crispin, Jose C et al. (2013) cAMP-responsive element modulator * (CREM*) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease. J Biol Chem 288:31880-7
Deng, Guo-Min; Beltran, Jessica; Chen, Chen et al. (2013) T cell CD3ýý deficiency enables multiorgan tissue inflammation. J Immunol 191:3563-7
Davis, Trevor E; Kis-Toth, Katalin; Szanto, Attila et al. (2013) Glucocorticoids suppress T cell function by up-regulating microRNA-98. Arthritis Rheum 65:1882-90
Grammatikos, Alexandros P; Ghosh, Debjani; Devlin, Amy et al. (2013) Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling. PLoS One 8:e74550
Ghosh, Debjani; Tsokos, George C; Kyttaris, Vasileios C (2012) c-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells. J Biol Chem 287:11833-41

Showing the most recent 10 out of 94 publications